Renal Function after Radioligand Treatment with 177Lu-PSMA-617

被引：0
作者：
Ngoc, Christina Nguyen [1 ]
Happel, Christian [1 ]
Davis, Karen [1 ]
Groener, Daniel [1 ]
Mader, Nicolai [1 ]
Mandel, Philipp [2 ]
Tselis, Nikolaos [3 ]
Gruenwald, Frank [1 ]
Sabet, Amir [1 ]
机构：
[1] Univ Hosp Frankfurt, Nucl Med, Frankfurt, Germany
[2] Univ Hosp Frankfurt, Urol, Frankfurt, Germany
[3] Univ Hosp Frankfurt, Radiooncol, Frankfurt, Germany
来源：
JOURNAL OF NUCLEAR MEDICINE | 2020年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
1279
引用
收藏
页数：2
相关论文
共 50 条
[21]   177Lu-PSMA-617 radioligand therapy for a patient with lymph node metastatic prostate cancer [J].
von Eyben, Finn E. ;
Kiljunen, Timo ;
Joensuu, Timo ;
Kairemo, Kalevi ;
Uprimny, Christian ;
Virgolini, Irene .
ONCOTARGET, 2017, 8 (39) :66112-66116
[22]   A Hangover Under 177Lu-PSMA-617 Therapy [J].
Poterszman, Nathan ;
Somme, Laura ;
Bund, Caroline ;
Hutt, Emilie ;
Somme, Francois .
CLINICAL NUCLEAR MEDICINE, 2024, 49 (06) :582-583
[23]   Radiation Dosimetry in 177Lu-PSMA-617 Therapy [J].
Jackson, Price ;
Hofman, Michael ;
McIntosh, Lachlan ;
Buteau, James Patrick ;
Kumar, Aravind Ravi .
SEMINARS IN NUCLEAR MEDICINE, 2022, 52 (02) :243-254
[24]   177Lu-PSMA-617 Radioligand Therapy in Patient With Prostate Cancer Sciatic Nerve Metastasis [J].
Tonnelet, David ;
Edet-Sanson, Agathe ;
Augusto, Laetitia ;
Cabourg, Marine ;
Thureau, Sebastien .
CLINICAL NUCLEAR MEDICINE, 2024, 49 (12) :E668-E669
[25]   Establishing 177Lu-PSMA-617 Radioligand Therapy in a Syngeneic Model of Murine Prostate Cancer [J].
Fendler, Wolfgang P. ;
Stuparu, Andreea D. ;
Evans-Axelsson, Susan ;
Luckerath, Katharina ;
Wei, Liu ;
Kim, Woosuk ;
Poddar, Soumya ;
Said, Jonathan ;
Radu, Caius G. ;
Eiber, Matthias ;
Czernin, Johannes ;
Slavik, Roger ;
Herrmann, Ken .
JOURNAL OF NUCLEAR MEDICINE, 2017, 58 (11) :1786-1792
[26]   Real-World Experience with 177Lu-PSMA-617 Radioligand Therapy After Food and Drug Administration Approval [J].
Tuchayi, Abuzar Moradi ;
Yadav, Surekha ;
Jiang, Fei ;
Kim, Sarasa T. ;
Saelee, Rachelle K. ;
Morley, Amanda ;
Juarez, Roxanna ;
Lawhn-Heath, Courtney ;
Wang, Yingbing ;
de Kouchkovsky, Ivan ;
Hope, Thomas A. .
JOURNAL OF NUCLEAR MEDICINE, 2024, 65 (05) :735-739
[27]   177Lu-Vipivotide Tetraxetan (177Lu-PSMA-617, Pluvicto) Therapy [J].
Clements, Sarah ;
Tempesta, Daniel ;
Jacene, Heather .
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY, 2022, 50 (03) :213-214
[28]   Prostate Cancer Treatment: 177Lu-PSMA-617 Considerations, Concepts, and Limitations [J].
Sartor, Oliver ;
Herrmann, Ken .
JOURNAL OF NUCLEAR MEDICINE, 2022, 63 (06) :823-829
[29]   Successful Treatment of Hepatic Metastases of Hormone Refractory Prostate Cancer Using Radioligand Therapy With 177Lu-PSMA-617 [J].
Wei, Xiao ;
Schlenkhoff, Carl ;
Sopora, Claudia ;
Essler, Markus ;
Ahmadzadehfar, Hojjat .
CLINICAL NUCLEAR MEDICINE, 2016, 41 (11) :894-+
[30]   Safety and efficacy of 177lu-PSMA-617 radioligand therapy in patients with mCRPC: A multicenter study. [J].
Rahbar, Kambiz ;
Ahmadzadehfar, Hojjat ;
Kratochwil, Clemens ;
Baum, Richard P. ;
Schmidt, Matthias ;
Pfestroff, Andreas ;
Prasad, Vikas ;
Heinzel, Aelxander ;
Ruf, Juri ;
Eveslage, Maria ;
Boegemann, Martin ;
Fendler, Wolfgang ;
Krause, Bernd J. .
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
12345